Bio-artificial pancreas to fight diabetes

Israel’s Kadimastem is partnering with France’s Defymed to develop a stem cell-based bio-artificial pancreas for the treatment of type 1 diabetes. They received NIS 5.4 million from the European Commission and the intergovernmental research organization EUREKA.,7340,L-3749642,00.html

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *